Odyssey Health Inc (ODYY) Return on Equity ROE from the third quarter 2026 to third quarter 2025 and annually, average high and low, overall ranking from Apr 30 2026 to Apr 30 2025 - CSIMarket
CSIMarket
 


Odyssey Health Inc   (ODYY)

Odyssey Health Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Odyssey Health Inc in the third quarter 2026?
Due to the lack of equity, it was not possible to calculate Odyssey Health Inc 's return on equity (ROE) in its third quarter 2026

What is ROE?




Return On Equity (Apr 30 2026)
III. Quarter
(Jan 31 2026)
II. Quarter
(Oct 31 2025)
I. Quarter
(Jul 31 2025)
IV. Quarter
(Apr 30 2025)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -4 -5 -1 -2 -14
Return On Equity (TTM) - - - - -
ODYY's Total Ranking # # # # #
Equity (TTM) in Millions -10 -7 -7 -7 7
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





ODYY Annual Return On Equity (Jul 31 2025)
2025
(Jul 31 2024)
2024
(Jul 31 2023)
2023
(Jul 31 2022)
2022
(Jul 31 2021)
2021
Total Equity in Millions -7 -5 -6 -5 -3
Y / Y Equity Change - - - - -
Net Income in Millions -2 -1 -6 -8 -17
Y / Y Net Income Change - - - - -
Return On Equity - - - - -





More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ODYY's' Return on Equity at Yahoo Finance
ODYY's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ODYY's Competitors
Subscribers only: Roe for Odyssey Health Inc 's Suppliers
Subscribers only: Return On Equity for ODYY's Customers




Companies with similar Return On Equity at Apr 30 2026, within Healthcare Sector ROE
Halozyme Therapeutics Inc   126.27 %
Petros Pharmaceuticals inc   124.23 %
Advanced Biomed Inc.  121.71 %
Medpace Holdings Inc   120.89 %
Capforce Inc   110.42 %
Eli Lilly And Company  101.17 %
Qhslab Inc   91.63 %
Amgen Inc   89.41 %
Exelixis Inc   88.60 %
Entera Bio Ltd   87.97 %
Tg Therapeutics Inc   87.36 %
Alnylam Pharmaceuticals Inc   86.11 %
Zevra Therapeutics Inc   81.34 %
Pulmatrix Inc   78.57 %
Earth Science Tech Inc   71.44 %
Idexx Laboratories Inc  70.87 %
Elite Pharmaceuticals Inc   68.60 %
Escalon Medical Corp   66.85 %
3m Company  65.54 %
Aurinia Pharmaceuticals Inc   64.48 %
Lifemd Inc   63.70 %
Zoetis Inc   61.63 %
Vaxart Inc   61.43 %
Dariohealth Corp   60.52 %
Nrc Health  57.25 %
Oramed Pharmaceuticals Inc  55.40 %
Innoviva Inc   47.59 %
Concentra Group Holdings Parent Inc   46.95 %
Liquidia Corporation  46.82 %
Agilent Technologies inc   44.45 %


Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.